Psychostimulants in the treatment of depression: A review of the evidence

CNS Drugs

Volumn 21, Issue 3, 2007, Pages 239-257

  Orr, Katy ^a   Taylor, David ^a  

^a SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DEXAMPHETAMINE; FLUOXETINE; IMIPRAMINE; METHAMPHETAMINE; METHYLPHENIDATE; MODAFINIL; MONOAMINE OXIDASE INHIBITOR; PEMOLINE; PHENELZINE; PLACEBO; PSYCHOSTIMULANT AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADJUVANT THERAPY; ADVANCED CANCER; AGITATION; ANOREXIA; ANXIETY; ASTHENIA; ATTENTION DEFICIT DISORDER; BIPOLAR DEPRESSION; CLINICAL TRIAL; CONFUSION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; DEPRESSION; DIARRHEA; DISEASE ASSOCIATION; DIZZINESS; DROWSINESS; DRUG DEPENDENCE; DRUG SAFETY; DRUG TOLERABILITY; DRUG TOLERANCE; DRUG WITHDRAWAL; DYSPNEA; EXCITEMENT; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART ATRIUM FIBRILLATION; HEART PALPITATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; HYPERVENTILATION; HYPOMANIA; HYPOTENSION; INFECTION; INSOMNIA; LONG TERM CARE; LOW DRUG DOSE; MAJOR DEPRESSION; MONOTHERAPY; MOOD DISORDER; MUSCLE HYPERTONIA; MYALGIA; NARCOLEPSY; NAUSEA; NERVOUSNESS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHINITIS; SEDATION; SENESCENCE; SIDE EFFECT; SINGLE DRUG DOSE; SOMNOLENCE; SPASTICITY; STROKE; SUPPOSITORY; SWEATING; TACHYCARDIA; TERMINAL DISEASE; TREMOR; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

AGED; CENTRAL NERVOUS SYSTEM STIMULANTS; CLINICAL TRIALS; DEPRESSIVE DISORDER; HUMANS;

EID: 33947272977     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200721030-00004     Document Type: Review

References (88)

1. Connell PH. Amphetamine dependence. Proc Roy Soc Med 1968; 61 (2): 170-81
2. Connell PH. Amphetamine psychosis. In: Maudsley Monographs no. 5. London: Oxford University Press, 1958
3. Janowsky DS, El-Yousef MK, Davis JM, et al. Provocation of schizophrenic symptoms by intravenous administration of methylphenidate. Arch Gen Psychiatry 1973; 28: 185-91
4. McClellan KJ, Spencer CM. Modafinil: a review of its pharmacology and clinical efficacy in the management of narcolepsy. CNS Drugs 1998; 9 (4): 311-24
5. Biederman J, Swanson JM, Wigal SB, et al. A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, doubleblind, and placebo-controlled study. J Clin Psychiatry 2006; 67 (5): 727-35
6. Mattes JA. Methylphenidate in mild depression: a double-blind controlled trial. J Clin Psychiatry 1985; 46 (12): 525-7
7. Little KY. d-Amphetamine versus methylphenidate effects in depressed inpatients. J Clin Psychiatry 1993; 54 (9): 349-55
8. Rickels K, Gingrich RL, McLaughlin FW, et al. Methylphenidate in mildly depressed outpatients. Clin Pharmacol Ther 1972; 13 (4): 595-601
9. O'Donnell M. Dexamphetamine compared with an inactive placebo in depression. Practitioner 1964; 192: 151-4
10. Robin AA, Wiseberg S. A controlled trial of methylphenidate (ritalin) in the treatment of depressive states. J Neurol Neurosurg Psychiatry 1958; 21: 55-7
11. Rickels K, Gordon PE, Gansman DH, et al. Pemoline and methylphenidate in mildly depressed outpatients. Clin Pharmacol Ther 1970; 11 (5): 698-710
12. Hare EH, Dominian J, Sharpe L. Phenelzine and dexamphetamine in depressive illness; a comparative trial. BMJ 1962; 5270: 9-12
13. Rudolf GDEM. The treatment of depression with desoxyephedrine (methedrine). J Ment Sci 1949; 95: 920-9
14. Wilbur DL, MacLean AR, Allen EV. Clinical observation on the effect of benzedrine sulphate: a study of patients with states of chronic exhaustion, depression and psychoneurosis. JAMA 1937; 109 (8): 549-54
15. Wagner GJ, Rabkin R. Effects of dextroamphetamine on depression and fatigue in men with HIV: a double-blind, placebo-controlled trial. J Clin Psychiatry 2000; 61 (6): 436-40
16. Kaplitz SE. Withdrawn, apathetic geriatric patients responsive to methylphenidate. J Am Geriatr Soc 1975; 23 (6): 271-6
17. DeBattista C, Lembke A, Solvason HB, et al. A prospective trial of modafinil as an adjunctive treatment of major depression. J Clin Psychopharmacol 2004; 24 (1): 87-90
18. Gwirtsman HE, Szuba MP, Toren L, et al. The antidepressant response to tricyclics in major depressives is accelerated with adjunctive use of methylphenidate. Psychopharmacol Bull 1994; 30 (2): 157-64
19. Rasmussen NA, Schroder P, Olsen LR, et al. Modafinil augmentation in depressed patients with partial response to antidepressants: a pilot study on self-reported symptoms covered by the major depression inventory (MDI) and the symptom checklist (SCL-92). Nord J Psychiatry 2005; 59 (3): 173-8
20. Fava M, Thase ME, DeBattista C. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. J Clin Psychiatry 2005; 66 (1): 85-93
21. DeBattista C, Doghramji K, Menza MA, et al. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study. J Clin Psychiatry 2003; 64 (9): 1057-64
22. Schwartz TL, Azhar N, Cole K, et al. An open-label study of adjunctive modafinil in patients with sedation related to serotonergic antidepressant therapy. J Clin Psychiatry 2004; 65 (9): 1223-7
23. Fawcett J, Kravitz HM, Zajecka JM, et al. CNS stimulant potentiation of monoamine oxidase inhibitors in treatment refractory depression. J Clin Psychopharmacol 1991; 11 (2): 127-32
24. Postolache TT, Rosenthal RN, Hellerstein DJ, et al. Early augmentation of sertraline with methylphenidate. J Clin Psychiatry 1999; 60 (2): 123-4
25. Markovitz PJ, Wagner S. An open-label trial of modafinil augmentation in patients with partial response to antidepressant therapy. J Clin Psychopharmacol 2003; 23 (2): 207-9
26. Macleod AD. Methylphenidate in terminal depression. J Pain Symptom Manage 1998; 16 (3): 193-8
27. Homsi J, Nelson KA, Sarhill N, et al. A phase II study of methylphenidate for depression in advanced cancer. Am J Hosp Palliat Care 2001; 18 (6): 403-7
28. Olin J, Masand P. Psychostimulants for depression in hospitalized cancer patients. Psychosomatics 1996; 37 (1): 57-62
29. Fernandez F, Adams F, Holmes VF, et al. Methylphenidate for depressive disorders in cancer patients. Psychosomatics 1987; 28 (9): 455-61
30. Meyers CA, Weitzner MA, Valentine AD, et al. Methylphenidate therapy improves cognition, mood and function of brain tumor patients. J Clin Oncol 1998; 16 (7): 2522-7
31. Grade C, Redford B, Chrostowski J, et al. Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Arch Phys Med Rehabil 1998; 79: 1047-50
32. Lazarus LW, Winemiller DR, Lingam VR, et al. Efficacy and side effects of methylphenidate for poststroke depression. J Clin Psychiatry 1992; 53 (12): 447-9
33. Masand P, Pickett P, Murray GB. Psychostimulants in post-stroke depression. J Neuropsychiatry Clin Neurosci 1991; 3 (1): 23-7
34. Lingam VR, Lazarus LW, Groves L, et al. Methylphenidate in treating poststroke depression. J Clin Psychiatry 1988; 49 (4): 151-3
35. Wagner GJ, Rabkin R, Rabkin JG. Dexamphetamine as a treatment for depression and low energy in AIDS patients: a pilot study. J Psychosom Res 1997; 42 (4): 407-11
36. Reynolds III CF, Frank E, Dew MA, et al. Treatment of 70 (+)-year-olds with recurrent major depression: excellent short-term but brittle long-term response. Am J Geriatr Psychiatry 1999; 7 (1): 64-9
37. Paykel ES, Ramana R, Cooper Z, et al. Residual symptoms after partial remission: an important outcome in depression. Psychol Med 1995; 25 (6): 1171-80
38. Lebowitz BD, Pearson JL, Schneider LS, et al. Diagnosis and treatment of depression in late life: consensus statement update. JAMA 1997; 278 (14): 1186-90
39. Geerlings SW, Beekman AT, Deeg DJ, et al. The longitudinal effect of depression on functional limitations and disability in older adults: an eight-wave prospective community-based study. Psychol Med 2001; 31 (8): 1361-71
40. Wallace AE, Kofoed LL, West AN. Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients. Am J Psychiatry 1995; 152 (6): 929-31
41. Lavretsky H, Kim MD, Kumar A, et al. Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial. J Clin Psychiatry 2003; 64 (12): 1410-4
42. Lavretsky H, Kumar A. Methylphenidate augmentation of citalopram in elderly depressed patients. Am J Geriatr Psychiatry 2001; 9 (3): 298-303
43. Jacobson A. The use of ritalin in psychotherapy of depression of the aged. Psychiatr Q 1958; 32: 474-83
44. Pickett P, Masand P, Murray GB. Psychostimulant treatment of geriatric depressive disorders secondary to medical illness. J Geriatr Psychiatry Neurol 1990; 3 (3): 146-51
45. Woods SW, Tesar GE, Murray GB, et al. Psychostimulant treatment of depressive disorders secondary to medical illness. J Clin Psychiatry 1986; 47 (1): 12-5
46. Masand P, Pickett P, Murray GB. Psychostimulants for secondary depression in medical illness. Psychosomatics 1991; 32 (2): 203-8
47. Rosenberg PB, Ahmed I, Hurwitz S. Methylphenidate in depressed medically ill patients. J Clin Psychiatry 1991; 52 (6): 263-7
48. Rothenhausler HB, Ehrentraut S, Degenfeld GV, et al. Treatment of depression with methylphenidate in patients difficult to wean from mechanical ventilation in the intensive care unit. J Clin Psychiatry 2000; 61 (10): 750-5
49. Landman ME, Preisig R, Perlman M. A practical mood stimulant. J Med Soc N J 1958; 55 (2): 55-8
50. Hornig-Rohan M, Amsterdam JD. Venlafaxine versus stimulant therapy in patients with dual diagnosis ADD and depresdate sion. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26: 585-9
51. Lundt L. Modafinil treatment in patients with measonal affective disorder/ winter depression: an open-label pilot study. Affect Disord 2004; 81: 173-8
52. El-Mallakh RS. An open study of methylphenidate in bipolar depression. Bipolar Disord 2000; 2: 56-9
53. Jonas AD. The adjunctive use of an intravenous amphetamine in psychotherapy. J Nerv Ment Dis 1954; 119: 135-47
54. Linet LS. Treatment refractory depression with a combination of fluoxetine and dexamphetamine. Am J Psychiatry 1989; 146 (6): 803-4
55. Menza MA, Kaufman KR, Castellanos A. Modafinil augmentation of antidepressant treatment in depression. J Clin Psychiatry 2000; 61 (5): 378-81
56. Xiong GL, Christopher EJ, Goebel J. Modafinil as an alternative to methylphenidate as augmentation for depression treatment. Psychosomatics 2005; 46 (6): 578-9
57. Schwartz TL, Leso L, Beale M, et al. Modafinil in the treatment of depression with severe comorbid medical illness. Psychosomatics 2002; 43 (3): 336-7
58. Ward NG, Lampe TH. A trial of dextroamphetamine in patients with involutional agitated depression. J Clin Psychiatry 1982; 43 (1): 35-6
59. Kaufman KR, Menza MA, Fitzsimmons A. Modafinil monotherapy in depression. Eur Psychiatry 2002; 17 (3): 167-9
60. Stiebel VG. Methylphenidate plasma levels in depressed patients with renal failure. Psychosomatics 1994; 35 (5): 498-500
61. Holmes TF, Sabaawi M, Fragala MR. Psychostimulant suppository treatment for depression in the gravely ill. J Clin Psychiatry 1994; 55 (6): 265-6
62. Kaufmann MW, Cassem NH, Murray GB, et al. Use of psychostimulants in medically ill patients with neurological disease and major depression. Can J Psychiatry 1984; 29 (1): 46-9
63. Kaufmann MW, Cassem NH, Murray GB, et al. The use of methylphenidate in depressed patients after cardiac surgery. Clin Psychiatry 1984; 45 (2): 82-4
64. Kaufmann MW, Murray GB. The use of d-amphetamine in medically ill depressed patients. J Clin Psychiatry 1982; 43 (11): 463-4
65. Kaufmann MW, Murray GB, Cassem NH. Use of psychostimulants in medically ill depressed patients. Psychosomatics 1982; 23 (8): 817-9
66. Block SD. Assessing and managing depression in the terminally ill patient. Ann Intern Med 2000; 132: 209-18
67. Sugden SG, Bourgeois JA. Modafinil monotherapy in post-stroke depression. Psychosomatics 2004; 45 (1): 80-1
68. Homsi J, Walsh D, Nelson KA, et al. Methylphenidate for depression in hospice practice. Am J Hosp Palliat Care 2000; 17 (6): 393-8
69. Sarhill N, Walsh D, Nelson KA, et al. Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study. Am J Hosp Palliat Care 2001; 18 (3): 187-92
70. Burns MM, Eisendrath SJ. Dextroamphetamine treatment for depression in terminally ill patients. Psychosomatics 1994; 35 (1): 80-3
71. Frye CB. Methylphenidate for depression in the elderly, medically ill patient. Am J Health Syst Pharm 1997; 54 (21): 2510-1
72. Gurian B, Rosowsky E. Low-dose methylphenidate in the very old. J Geriatr Psychiatry Neurol 1990; 3 (3): 152-4
73. Anderson IM, Nutt DJ, Deakin JF. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology. J Psychopharmacol 2000; 14 (1): 3-20
74. Fava GA. Can long-term treatment with antidepressant drugs worsen the course of depression? J Clin Psychiatry 2003; 64 (2): 123-33
75. Summary of product characteristics (SPC) for Provigil® 100 and 200mg tablets (modafinil) [online]. Available from URL: http://www.medicines.org.uk [Accessed 2006 Dec 27]
76. Summary of product characteristics (SPC) for Dexedrine® 5mg (dexamphetamine) [online]. Available from URL: http://www.medicines.org.uk [Accessed 2006 Dec 27]
77. Summary of product characteristics (SPC) for Equasym® 5, 10 and 20mg tablets (methylphenidate) [online]. Available from URL: http://www.medicines. org.uk [Accessed 2006 Dec 27]
78. Micromedex® healthcare series. Modafinil Drugdex® evaluation [online]. Available from URL: http://healthcare.micromedex.com [Accessed 2006 Feb 7]
79. Micromedex® healthcare series. Dexamphetmaine Drugdex® evaluation [online]. Available from URL: http://healthcare.micromedex.com [Accessed 2006 Feb 7]
80. Micromedex® healthcare series. Methylphenidate Drugdex® evaluation [online]. Available from URL: http://healthcare. micromedex.com [Accessed 2006 Feb 7]
81. Markowitz PJ, Wagner S. An open-label trial of modafinil augmentation in patients with partial response to antidepressant therapy. J Clin Psychopharmacol 2003; 23 (2): 207-8
82. Ross RG. Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder. Am J Psychiatry 2006; 163 (7): 1149-52
83. Koehler-Troy C, Strober M, Malenbaum R. Methylphenidate-induced mania in a prepubertal child. J Clin Psychiatry 1986; 47 (11): 566-7
84. Vorspan F, Warot D, Consoli A, et al. Mania in a boy treated with modafinil for narcolepsy. Am J Psychiatry 2005; 162 (4): 813-4
85. Food and Drug Administration. Drug Safety and Risk Management Advisory Committee meeting, 9-10 February 2006: table of contents [online]. Available from URL: http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4202_00_TOC.htm) [Accessed 2006 Apr 18]
86. Nissen SE. ADHD drugs and cardiovascular risk. N Engl J Med 2006; 354 (14): 1445-8
87. Bennett IL, Walker WE. Cardiac arrhythmias following the use of large doses of central nervous system stimulants. Am Heart J 1952; 44: 428
88. Anders T, Sharfstein S. ADHD drugs and cardiovascular risk [letter]. N Engl J Med 2006; 354 (21): 2296-8